LEMAITRE VASCULAR INC (LMAT)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Net sales | 64,232 | 59,871 | 54,819 | 55,849 |
| Cost of sales | 19,258 | 18,451 | 17,641 | 17,381 |
| Gross profit | 44,974 | 41,420 | 37,178 | 38,468 |
| Sales and marketing | 14,895 | 14,212 | 11,441 | 10,984 |
| Research and development | 3,541 | 4,095 | 3,656 | 4,284 |
| General and administrative | 10,396 | 10,487 | 8,933 | 8,820 |
| Total operating expenses | 28,832 | 28,794 | 24,030 | 24,088 |
| Income from operations | 16,142 | 12,626 | 13,148 | 14,380 |
| Interest income | 2,980 | 2,903 | 1,201 | 1,137 |
| Interest expense | 1,299 | 1,290 | - | - |
| Other income (loss), net | 247 | 2 | - | - |
| Foreign currency loss | - | - | 202 | -11 |
| Income before income taxes | 18,070 | 14,241 | 14,551 | 15,506 |
| Provision for income taxes | 4,291 | 3,230 | 3,410 | 3,680 |
| Net income | 13,779 | 11,011 | 11,141 | 11,826 |
| Basic (in dollars per share) | 0.61 | 0.49 | 0.5 | 0.53 |
| Basic (in shares) | 22,614,000 | 22,570,000 | 22,476,000 | 22,458,000 |
| Diluted (in dollars per share) | 0.6 | 0.48 | 0.49 | 0.52 |
| Diluted (in shares) | 22,892,000 | 22,899,000 | 22,836,000 | 22,725,000 |